ro 31-8472 has been researched along with captopril in 1 studies
*Captopril: A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. [MeSH]
*Captopril: A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. [MeSH]
| Studies (ro 31-8472) | Trials (ro 31-8472) | Recent Studies (post-2010) (ro 31-8472) | Studies (captopril) | Trials (captopril) | Recent Studies (post-2010) (captopril) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 10,320 | 1,514 | 890 |
| Protein | Taxonomy | ro 31-8472 (IC50) | captopril (IC50) |
|---|---|---|---|
| Leukotriene A-4 hydrolase | Homo sapiens (human) | 3.6 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.084 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0173 | |
| Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | 3.3 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.1004 | |
| Beta-lactamase | Pseudomonas aeruginosa | 5 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.011 | |
| Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bevilacqua, M; Conci, F; Norbiato, G; Rogolino, A; Santoli, E; Vago, T | 1 |
1 other study(ies) available for ro 31-8472 and captopril
| Article | Year |
|---|---|
Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Binding Sites; Captopril; Cell Membrane; Coronary Vessels; Enalaprilat; Female; Humans; In Vitro Techniques; Iodine Radioisotopes; Lung; Male; Mammary Arteries; Myocardium; Peptidyl-Dipeptidase A; Pyridazines; Radioligand Assay; Rats; Saphenous Vein; Testis; Veins | 1996 |